#gene therapy manufacturing
Discover 4 curated intelligence briefings related to this specific topic.
The Lean Paradox: Solving the Muscle Leak in the Age of GLP-1s
The GLP-1 revolution has delivered unprecedented weight loss, but a hidden cost has emerged. From New York to Tokyo, clinicians are racing to stop the 'muscle leak'—the loss of lean mass that threatens long-term metabolic health.
The Delivery Gap: Why Genomic Discovery is Outstripping the Bio-Factory
The race to cure rare diseases has hit a systemic wall. While genomic sequencing identifies targets in days, the infrastructure to manufacture these bespoke cures takes years, creating a dangerous delivery gap that leaves thousands behind.
Precision Vectoring Demands Molecular Rigor
A technical execution guide on optimizing viral vectors by integrating AI-assisted fragment discovery, signal peptide screening, and closed-system automation to overcome tumor heterogeneity and expression bottlenecks.
Eastern Europe Just Broke the Gene Therapy Bottleneck
While the US and Western Europe struggle with skyrocketing OpEx and talent shortages, a new corridor of CDMOs in Poland, Czechia, and Hungary is rewriting the rules of viral vector production, slashing lead times and costs for AAV and Lentivirus scaling.